{"DataElement":{"publicId":"3755637","version":"1","preferredName":"Chronic Graft Versus Host Disease Common Feature Name","preferredDefinition":"Term to describe a commonly occurring characteristic or clinical manifestation of chronic Graft versus Host Disease (cGVHD).","longName":"CGVHD_COM_FT_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"3755634","version":"1","preferredName":"Chronic Graft Versus Host Disease Common Feature","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Widely known or encountered; standard; of no special distinction or quality._A prominent or identifiable aspect, region, or site of interest.","longName":"CGVHD_COM_FEAT","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2676585","version":"1","preferredName":"Chronic Graft Versus Host Disease","preferredDefinition":"A disease or condition that persists or progresses over a long period of time.:An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","longName":"C14141:C3063","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3951A8C0-249F-64ED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-09-04","modifiedBy":"ONEDATA","dateModified":"2007-09-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3755632","version":"1","preferredName":"Common Feature","preferredDefinition":"Widely known or encountered; standard; of no special distinction or quality.:A prominent or identifiable aspect, region, or site of interest.","longName":"C43461:C73619","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common","conceptCode":"C43461","definition":"Widely known or encountered; standard; of no special distinction or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Feature","conceptCode":"C73619","definition":"A prominent or identifiable aspect, region, or site of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC411577-9B17-49BE-E040-BB89AD434EFB","latestVersionIndicator":"Yes","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC411577-9B28-49BE-E040-BB89AD434EFB","latestVersionIndicator":"Yes","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3755635","version":"1","preferredName":"Chronic Graft Versus Host Disease Common Feature Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"CGHVD_COM_FT_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"BOOP","valueDescription":"Bronchiolitis Obliterans-organizing Pneumonia","ValueMeaning":{"publicId":"3755636","version":"1","preferredName":"Bronchiolitis Obliterans-organizing Pneumonia","longName":"3755636","preferredDefinition":"Inflammation of the bronchioles with obstruction by fibrous granulation tissue or bronchial exudate. It may follow inhalation of irritating gases or foreign bodies and it complicates pneumonia.: Inflammation of the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchiolitis Obliterans","conceptCode":"C62580","definition":"Inflammation of the bronchioles with obstruction by fibrous granulation tissue or bronchial exudate. It may follow inhalation of irritating gases or foreign bodies and it complicates pneumonia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pneumonia","conceptCode":"C3333","definition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC41D01B-C71F-6455-E040-BB89AD430E87","latestVersionIndicator":"Yes","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC41D01B-C738-6455-E040-BB89AD430E87","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","deletedIndicator":"No"},{"value":"Pruritus","valueDescription":"Pruritus","ValueMeaning":{"publicId":"2757871","version":"1","preferredName":"Pruritus","longName":"2757871","preferredDefinition":"An intense itching sensation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pruritus","conceptCode":"C3344","definition":"An intense itching sensation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D43A-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC41D01B-C742-6455-E040-BB89AD430E87","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","deletedIndicator":"No"},{"value":"Maculopapular rash","valueDescription":"Maculopapular Lesion","ValueMeaning":{"publicId":"2946124","version":"1","preferredName":"Maculopapular Lesion","longName":"2946124","preferredDefinition":"A skin condition consisting of both macules and papules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maculopapular Lesion","conceptCode":"C75579","definition":"A skin condition consisting of both macules and papules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-69EB-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC41D01B-C756-6455-E040-BB89AD430E87","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","deletedIndicator":"No"},{"value":"Erythema","valueDescription":"Erythema","ValueMeaning":{"publicId":"2585191","version":"1","preferredName":"Erythema","longName":"2585191","preferredDefinition":"Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of causes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erythema","conceptCode":"C26901","definition":"Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26809F27-C2D0-70B5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC41D01B-C761-6455-E040-BB89AD430E87","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","deletedIndicator":"No"},{"value":"Gingivitis","valueDescription":"Gingivitis","ValueMeaning":{"publicId":"2936635","version":"1","preferredName":"Gingivitis","longName":"2936635","preferredDefinition":"Gingivitis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72392025-F576-659B-E040-BB89AD43568A","latestVersionIndicator":"Yes","beginDate":"2009-08-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-08-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC41D01B-C76C-6455-E040-BB89AD430E87","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","deletedIndicator":"No"},{"value":"Mucositis","valueDescription":"Mucositis","ValueMeaning":{"publicId":"2751408","version":"1","preferredName":"Mucositis","longName":"2751408","preferredDefinition":"A complication of some cancer therapies in which the lining of the digestive system becomes inflamed. Often seen as sores in the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Mucositis","conceptCode":"C3853","definition":"Inflammation of the mucous membranes lining the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0BA2-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC41D01B-C776-6455-E040-BB89AD430E87","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","deletedIndicator":"No"},{"value":"Pain","valueDescription":"Pain","ValueMeaning":{"publicId":"3123760","version":"1","preferredName":"Pain","longName":"3123760","preferredDefinition":"A disorder characterized by the sensation of marked discomfort, distress or agony.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pain","conceptCode":"E11167","definition":"A disorder characterized by the sensation of marked discomfort, distress or agony.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BC4736B-250C-40DF-E040-BB89AD435D6D","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-07-19","modifiedBy":"ONEDATA","dateModified":"2010-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC41D01B-C781-6455-E040-BB89AD430E87","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","deletedIndicator":"No"},{"value":"Thrombocytopenia","valueDescription":"Thrombocytopenia","ValueMeaning":{"publicId":"2946035","version":"1","preferredName":"Thrombocytopenia","longName":"2946035","preferredDefinition":"A condition in which there is an abnormally small number of platelets in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenia","conceptCode":"C3408","definition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D443-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E1E5-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Peripheral neuropathy","valueDescription":"Neuropathy","ValueMeaning":{"publicId":"2751427","version":"1","preferredName":"Neuropathy","longName":"2751427","preferredDefinition":"A disorder affecting the cranial nerves or the peripheral nervous system.  It is manifested with pain, tingling, numbness, and muscle weakness.  It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuropathy","conceptCode":"C4731","definition":"A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC8C1F0-9010-1819-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E1FA-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Pericardial or pleural effusions","valueDescription":"Pericardial Or Pleural Effusion","ValueMeaning":{"publicId":"3766433","version":"1","preferredName":"Pericardial Or Pleural Effusion","longName":"3766433","preferredDefinition":"Located around the heart or relating to or affecting the pericardium.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Of or pertaining to the pleura.: A collection of fluid in a body cavity.  It may be the result of a non-neoplastic disorder (e.g. heart failure) or a tumor (e.g. carcinoma of the lung). -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pericardial","conceptCode":"C38001","definition":"Located around the heart or relating to or affecting the pericardium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pleural","conceptCode":"C25223","definition":"Of or pertaining to the pleura.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Effusion","conceptCode":"C3003","definition":"A collection of fluid in a body cavity, which may be the result of a non-neoplastic disorder (e.g. heart failure) or a tumor (e.g. carcinoma of the lung).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCED4AE8-E20A-33A5-E040-BB89AD430FDC","latestVersionIndicator":"Yes","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E223-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Nephrotic Syndrome","valueDescription":"Nephrotic Syndrome","ValueMeaning":{"publicId":"3766434","version":"1","preferredName":"Nephrotic Syndrome","longName":"3766434","preferredDefinition":"Clinical association of heavy PROTEINURIA, HYPOALBUMINEMIA, and generalized EDEMA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nephrotic Syndrome","conceptCode":"C34845","definition":"A collection of symptoms that include severe edema, proteinuria, and hypoalbuminemia; it is indicative of renal dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCED4AE8-E22D-33A5-E040-BB89AD430FDC","latestVersionIndicator":"Yes","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E246-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Myasthenia Gravis","valueDescription":"Myasthenia Gravis","ValueMeaning":{"publicId":"3143924","version":"1","preferredName":"Myasthenia Gravis","longName":"3143924","preferredDefinition":"A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness.  It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis","conceptCode":"C60989","definition":"A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness. It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9167B9F7-3DD6-C748-E040-BB89AD432898","latestVersionIndicator":"Yes","beginDate":"2010-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-29","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E250-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Lymphopenia","valueDescription":"Lymphopenia","ValueMeaning":{"publicId":"2562733","version":"1","preferredName":"Lymphopenia","longName":"2562733","preferredDefinition":"An abnormally small number of lymphocytes in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphopenia","conceptCode":"C26823","definition":"An abnormally small number of lymphocytes in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C21A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E25A-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Hypo or Hyper gamma globulinemia","valueDescription":"Hypogammaglobulinemia Or Hypergammaglobulinemia Laboratory Procedure","ValueMeaning":{"publicId":"3766436","version":"1","preferredName":"Hypogammaglobulinemia Or Hypergammaglobulinemia Laboratory Procedure","longName":"3766436","preferredDefinition":"A condition in which the level of immunoglobulins (antibodies) in the blood is low and the risk of infection is high.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An excess of GAMMA-GLOBULINS in the blood. It is seen frequently in chronic infectious diseases. (Dorland, 27th ed): Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypogammaglobulinemia","conceptCode":"C26931","definition":"A decreased level of serum immunoglobulins. It may be inherited or acquired. It is caused by decreased or inefficient production of immunoglobulins from B cells or by a decrease in the numbers of B cells themselves. Low levels of immunoglobulins will affect the immune system's ability to combat bacterial infection. Supplementation of immunoglobulins is needed to prevent worsening outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hypergammaglobulinemia","conceptCode":"C34705","definition":"A laboratory test result indicating abnormally high concentrations of gamma globulins in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCED4AE8-E26B-33A5-E040-BB89AD430FDC","latestVersionIndicator":"Yes","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E284-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Eosinophilia","valueDescription":"Eosinophilia","ValueMeaning":{"publicId":"2793850","version":"1","preferredName":"Eosinophilia","longName":"2793850","preferredDefinition":"A condition in which the number of eosinophils (a type of white blood cell) in the blood is greatly increased. Eosinophilia is often a response to infection or allergens (substances that cause an allergic response).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eosinophilia","conceptCode":"C3015","definition":"Abnormal high level of eosinophils in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"594ACCA7-61B4-720E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-15","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E28E-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Cardiac conduction abnormality or cardiomyopathy","valueDescription":"Heart Conduction Disorder Or Cardiomyopathy Abnormality","ValueMeaning":{"publicId":"3766437","version":"1","preferredName":"Heart Conduction Disorder Or Cardiomyopathy Abnormality","longName":"3766437","preferredDefinition":"A disorder affecting the conduction system that sends electrical signals in the myocardium.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.: A condition that differs from the usual physical or mental state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiac Conduction Disorder","conceptCode":"C78245","definition":"A disorder affecting the conduction system that sends electrical signals in the myocardium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cardiomyopathy","conceptCode":"C34830","definition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCED4AE8-E29E-33A5-E040-BB89AD430FDC","latestVersionIndicator":"Yes","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E2B7-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Autoantibodies (AIHA and ITP)","valueDescription":"Autoantibody","ValueMeaning":{"publicId":"2793852","version":"1","preferredName":"Autoantibody","longName":"2793852","preferredDefinition":"Abnormal immunoproteins that act against the body's own tissues because they have been mistakenly identified as being foreign.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoantibody","conceptCode":"C48966","definition":"An antibody acting against tissues of the organism that produces it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"594ACCA7-6202-720E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E2CB-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Ascites","valueDescription":"Ascites","ValueMeaning":{"publicId":"3123209","version":"1","preferredName":"Ascites","longName":"3123209v1.00","preferredDefinition":"The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peritoneal Effusion","conceptCode":"C2885","definition":"The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBD6A24-E461-9B0C-E040-BB89AD430E98","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-07-19","modifiedBy":"KUMMEROA","dateModified":"2023-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCED4AE8-E2D6-33A5-E040-BB89AD430FDC","beginDate":"2013-05-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-17","modifiedBy":"ONEDATA","dateModified":"2013-05-17","deletedIndicator":"No"},{"value":"Failure to thrive","valueDescription":"Failure to Thrive","ValueMeaning":{"publicId":"3854253","version":"1","preferredName":"Failure to Thrive","longName":"3854253","preferredDefinition":"A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Failure to Thrive","conceptCode":"C107587","definition":"A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3D82D79-08D5-7EED-E040-BB89AD433B9E","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3691E92-8863-3019-E053-F662850A01B7","beginDate":"2020-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Weight loss","valueDescription":"Weight Loss","ValueMeaning":{"publicId":"2757889","version":"1","preferredName":"Weight Loss","longName":"2757889","preferredDefinition":"A reduction in overall body mass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weight Loss","conceptCode":"C3445","definition":"A reduction in total body weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D6B6-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3691E92-886E-3019-E053-F662850A01B7","beginDate":"2020-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Diarrhea","valueDescription":"Diarrhea","ValueMeaning":{"publicId":"4395762","version":"1","preferredName":"Diarrhea","longName":"4395762","preferredDefinition":"Watery bowel movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D82F-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3691E92-8879-3019-E053-F662850A01B7","beginDate":"2020-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Vomiting","valueDescription":"Vomiting","ValueMeaning":{"publicId":"4395791","version":"1","preferredName":"Vomiting","longName":"4395791","preferredDefinition":"Forceful ejection of the contents of the stomach through the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vomiting","conceptCode":"C3442","definition":"Forceful ejection of the contents of the stomach through the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DBF3-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3691E92-8883-3019-E053-F662850A01B7","beginDate":"2020-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Nausea","valueDescription":"Nausea","ValueMeaning":{"publicId":"5040701","version":"1","preferredName":"Nausea","longName":"5040701","preferredDefinition":"Upper abdominal discomfort associated with an urge to vomit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nausea","conceptCode":"C3258","definition":"Upper abdominal discomfort associated with an urge to vomit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2354E479-8671-0992-E050-BB89AD433614","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3691E92-888D-3019-E053-F662850A01B7","beginDate":"2020-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"},{"value":"Anorexia","valueDescription":"Anorexia","ValueMeaning":{"publicId":"2562627","version":"1","preferredName":"Anorexia","longName":"2562627","preferredDefinition":"Loss of appetite.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anorexia","conceptCode":"C2875","definition":"Loss of appetite.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CURTIST","dateModified":"2009-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3691E92-8897-3019-E053-F662850A01B7","beginDate":"2020-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-04-16","modifiedBy":"ONEDATA","dateModified":"2020-04-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC41D01B-C709-6455-E040-BB89AD430E87","latestVersionIndicator":"Yes","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"COOPERM","dateModified":"2020-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Common Feature","type":"Preferred Question Text","description":"Common Feature","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DC41D01B-C794-6455-E040-BB89AD430E87","latestVersionIndicator":"Yes","beginDate":"2013-05-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-08","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeDescription":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}